Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial

BACKGROUND: Elderly patients have been often excluded from or underrepresented in the study populations of combination chemotherapy trials. The primary end point of this study was to determine the response rate and the toxicity of the weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) regim...

Descripción completa

Detalles Bibliográficos
Autores principales: Santini, D, Graziano, F, Catalano, V, Di Seri, M, Testa, E, Baldelli, AM, Giordani, P, La Cesa, A, Spalletta, B, Vincenzi, B, Russo, A, Caraglia, M, Virzi, V, Cascinu, S, Tonini, G
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1475875/
https://www.ncbi.nlm.nih.gov/pubmed/16686939
http://dx.doi.org/10.1186/1471-2407-6-125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1475875/
https://www.ncbi.nlm.nih.gov/pubmed/16686939
http://dx.doi.org/10.1186/1471-2407-6-125

Ejemplares similares